Van Cutsem E - Search Results

1

The role of chemotherapy in the current treatment of gastric cancer.

Van Cutsem E, Haller D, Ohtsu A. Van Cutsem E, et al. Gastric Cancer. 2002;5 Suppl 1:17-22. doi: 10.1007/s10120-002-0219-y. Gastric Cancer. 2002. PMID: 12772882 Review.

2

Etoposide, leucovorin and 5-fluorouracil in advanced gastric cancer: a phase II study.

Van Cutsem E, Filez L, Dewyspelaere J, Penninckx F, Janssens J. Van Cutsem E, et al. Anticancer Res. 1995 May-Jun;15(3):1079-80. Anticancer Res. 1995. PMID: 7645929 Clinical Trial.

3

A glimpse of the future. new directions in the treatment of colorectal cancer.

Van Cutsem E. Van Cutsem E. Eur J Cancer. 1996;32A Suppl 5:S23-7. doi: 10.1016/s0959-8049(96)00320-6. Eur J Cancer. 1996. PMID: 8958039 Review.

4

Future developments with 'Tomudex' (raltitrexed).

Van Cutsem E. Van Cutsem E. Anticancer Drugs. 1997 Aug;8 Suppl 2:S33-8. doi: 10.1097/00001813-199708002-00007. Anticancer Drugs. 1997. PMID: 9376636 Review.

5

A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer.

Van Cutsem E, Pozzo C, Starkhammar H, Dirix L, Terzoli E, Cognetti F, Humblet Y, Garufi C, Filez L, Gruia G, Cote C, Barone C. Van Cutsem E, et al. Ann Oncol. 1998 Nov;9(11):1199-204. doi: 10.1023/a:1008478405634. Ann Oncol. 1998. PMID: 9862050 Free article. Clinical Trial.

6

Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study Group.

Van Cutsem E, Blijham GH. Van Cutsem E, et al. Semin Oncol. 1999 Feb;26(1 Suppl 5):13-20. Semin Oncol. 1999. PMID: 10213010 Clinical Trial.

7

The medical treatment of colorectal cancer: actual status and new developments.

Van Cutsem E, Peeters M, Verslype C, Filez L, Haustermans K, Janssens J. Van Cutsem E, et al. Hepatogastroenterology. 1999 Mar-Apr;46(26):709-16. Hepatogastroenterology. 1999. PMID: 10370599 Review.

8

Developments in fluoropyrimidine therapy for gastrointestinal cancer.

Van Cutsem E, Peeters M. Van Cutsem E, et al. Curr Opin Oncol. 1999 Jul;11(4):312-7. doi: 10.1097/00001622-199907000-00012. Curr Opin Oncol. 1999. PMID: 10416885 Review.

9

Raltitrexed (Tomudex) in combination treatment for colorectal cancer: new perspectives.

Van Cutsem E. Van Cutsem E. Eur J Cancer. 1999 Mar;35 Suppl 1:S1-2. doi: 10.1016/s0959-8049(99)00040-4. Eur J Cancer. 1999. PMID: 10645206 Review.

10

The treatment of advanced colorectal cancer: where are we now and where do we go?

Van Cutsem E, Verslype C, Demedts I. Van Cutsem E, et al. Best Pract Res Clin Gastroenterol. 2002 Apr;16(2):319-30. doi: 10.1053/bega.2002.0288. Best Pract Res Clin Gastroenterol. 2002. PMID: 11969241 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters